Our finding that the mislocalisation of GIST-associated PDGFRα mutant proteins can be prevented (Figure 3B) and reversed (Figure 3C) by the treatment with TKIs could be of importance for therapy. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.